Low FODMAP Diet in Patients With IBS

NCT ID: NCT05618106

Last Updated: 2025-04-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

9 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-03-01

Study Completion Date

2020-02-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim was aimed to investigate if all carbohydrate groups eliminated in the Low FODMAP diet are equally important in relieving gastrointestinal symptoms in IBS.

in a randomized cross-over design to three different carbohydrate-modified diets: A) Low Polyol diet, B) Low FOS+GOS diet, and C) Low FODMAP diet for three months without wash-out-periods. Gastrointestinal symptoms, Quality of life was measured at baseline and after each intervention diet.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Low FODMAP diets contain 3 major types of carbohydrates to be avoided. The clasical diet is very difficult to maintain over longer periods of time. Therefore, we aimed to investigate if all carbohydrate groups in the Low FODMAP diet are equally important in relieving gastrointestinal symptoms in IBS.

Patients diagnosed with IBS according to the Rome III criteria were randomised in a cross-over design to three different carbohydrate-modified diets: A) Low Polyol diet, B) Low FOS+GOS diet, and C) Low FODMAP diet for a total of three months without wash-out-periods. Gastrointestinal symptoms were assessed by the Birmingham IBS questionnaire and adequate relief (IBS-AR). Quality of life was measured by the IBS Quality of Life Scale questionnaire (IBS-QOL). All registrations were performed at baseline and after each intervention diet.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Irritable Bowel Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Cross-over of 3 variations of the low FODMAP diet excluding 1 of the 3 components in every period
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

low FODMAP diet

Diet low in all kinds of FODMAPS

Group Type EXPERIMENTAL

Low FODMAP DIET = Diet with Low polyol, FOS and GOS

Intervention Type OTHER

Low Polyol diet

Low Fodmap diet but polyols allowed

Diet low in FOS and GOS

Group Type PLACEBO_COMPARATOR

Low FODMAP DIET = Diet with Low polyol, FOS and GOS

Intervention Type OTHER

Low Polyol diet

Low Fodmap diet but FOS and GOS allowed

Diet low in polyols

Group Type ACTIVE_COMPARATOR

Low FODMAP DIET = Diet with Low polyol, FOS and GOS

Intervention Type OTHER

Low Polyol diet

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Low FODMAP DIET = Diet with Low polyol, FOS and GOS

Low Polyol diet

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* IBS diagnosed by the Rome III criteria and
* referred to the clinic for treatment by diet

Exclusion Criteria

* Dementia
* lack of ability to speak Danish
* additional chronic diseases prevailing participation
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Jens Rikardt Andersen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jens Rikardt Andersen

Assoc Prof

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jens R Andersen, MD, MPA

Role: STUDY_CHAIR

University of Copenhagen

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Copenhagen

Copenhagen, Frederiksberg, Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FODMAP

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Comparison Between Low FODMAP and SSRD in IBS
NCT05192603 ENROLLING_BY_INVITATION NA